FLUOGUIDE A/S DK -1 Asset Resilience Ratio
FLUOGUIDE A/S DK -1 asset resilience ratio. FLUOGUIDE A/S DK -1 (96X) has an Asset Resilience Ratio of 34.00% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 96X cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of FLUOGUIDE A/S DK -1 (2025–2025)
Asset resilience ratio of FLUOGUIDE A/S DK -1 from 2025 to 2025. This chart shows how FLUOGUIDE A/S DK -1's Asset Resilience Ratio has changed over time. Read 96X current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down FLUOGUIDE A/S DK -1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is FLUOGUIDE A/S DK -1's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €30.02 Million | 34.0% |
| Total Liquid Assets | €30.02 Million | 34.00% |
Asset Resilience Insights
- Very High Liquidity: FLUOGUIDE A/S DK -1 maintains exceptional liquid asset reserves at 34.00% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
FLUOGUIDE A/S DK -1 Industry Peers by Asset Resilience Ratio
Compare FLUOGUIDE A/S DK -1's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578 |
Biotechnology | 21.11% |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278 |
Biotechnology | 4.69% |
|
Neuren Pharmaceuticals Ltd
AU:NEU |
Biotechnology | 90.43% |
|
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513 |
Biotechnology | 35.16% |
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294 |
Biotechnology | 23.15% |
|
Wuhan Keqian Biology Co Ltd
SHG:688526 |
Biotechnology | 19.42% |
|
Achieve Life Sciences Inc
F:SP4P |
Biotechnology | 3.60% |
FLUOGUIDE A/S DK -1 Asset Resilience Ratio by Year (2025–2025)
FLUOGUIDE A/S DK -1 asset resilience ratio by year from 2025 to 2025. The table below shows the annual Asset Resilience Ratio data for FLUOGUIDE A/S DK -1.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 34.00% | €30.02 Million ≈ $35.09 Million |
€88.29 Million ≈ $103.22 Million |
-- |
About FLUOGUIDE A/S DK -1
FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatmen… Read more